370 related articles for article (PubMed ID: 26836009)
1. Effects of Acyclovir, Foscarnet, and Ribonucleotides on Herpes Simplex Virus-1 DNA Polymerase: Mechanistic Insights and a Novel Mechanism for Preventing Stable Incorporation of Ribonucleotides into DNA.
Vashishtha AK; Kuchta RD
Biochemistry; 2016 Feb; 55(7):1168-77. PubMed ID: 26836009
[TBL] [Abstract][Full Text] [Related]
2. DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions.
Andrei G; Fiten P; Froeyen M; De Clercq E; Opdenakker G; Snoeck R
Antivir Ther; 2007; 12(5):719-32. PubMed ID: 17713155
[TBL] [Abstract][Full Text] [Related]
3. Differential impact of various substitutions at codon 715 in region II of HSV-1 and HCMV DNA polymerases.
Zarrouk K; Zhu X; Goyette N; Piret J; Shi R; Boivin G
Antiviral Res; 2021 Apr; 188():105046. PubMed ID: 33588012
[TBL] [Abstract][Full Text] [Related]
4. The Anti-Human Immunodeficiency Virus Drug Tenofovir, a Reverse Transcriptase Inhibitor, Also Targets the Herpes Simplex Virus DNA Polymerase.
Andrei G; Gillemot S; Topalis D; Snoeck R
J Infect Dis; 2018 Feb; 217(5):790-801. PubMed ID: 29186456
[TBL] [Abstract][Full Text] [Related]
5. Polymerase and exonuclease activities in herpes simplex virus type 1 DNA polymerase are not highly coordinated.
Vashishtha AK; Kuchta RD
Biochemistry; 2015 Jan; 54(2):240-9. PubMed ID: 25517265
[TBL] [Abstract][Full Text] [Related]
6. Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility.
Piret J; Goyette N; Eckenroth BE; Drouot E; Götte M; Boivin G
J Virol; 2015 Apr; 89(8):4636-44. PubMed ID: 25673718
[TBL] [Abstract][Full Text] [Related]
7. Finger domain mutation affects enzyme activity, DNA replication efficiency, and fidelity of an exonuclease-deficient DNA polymerase of herpes simplex virus type 1.
Tian W; Hwang YT; Lu Q; Hwang CB
J Virol; 2009 Jul; 83(14):7194-201. PubMed ID: 19420083
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of herpes simplex virus DNA polymerase by purine ribonucleoside monophosphates.
Frank KB; Cheng YC
J Biol Chem; 1986 Feb; 261(4):1510-3. PubMed ID: 3003073
[TBL] [Abstract][Full Text] [Related]
9. Herpes Simplex Virus 1 DNA Polymerase RNase H Activity Acts in a 3'-to-5' Direction and Is Dependent on the 3'-to-5' Exonuclease Active Site.
Lawler JL; Mukherjee P; Coen DM
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237844
[TBL] [Abstract][Full Text] [Related]
10. Hydroxyurea enhances the activity of acyclovir and cidofovir against herpes simplex virus type 1 resistant strains harboring mutations in the thymidine kinase and/or the DNA polymerase genes.
Sergerie Y; Boivin G
Antiviral Res; 2008 Jan; 77(1):77-80. PubMed ID: 17913252
[TBL] [Abstract][Full Text] [Related]
11. A point mutation within conserved region VI of herpes simplex virus type 1 DNA polymerase confers altered drug sensitivity and enhances replication fidelity.
Hwang YT; Zuccola HJ; Lu Q; Hwang CB
J Virol; 2004 Jan; 78(2):650-7. PubMed ID: 14694096
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of the herpes simplex virus 1 DNA polymerase.
Liu S; Knafels JD; Chang JS; Waszak GA; Baldwin ET; Deibel MR; Thomsen DR; Homa FL; Wells PA; Tory MC; Poorman RA; Gao H; Qiu X; Seddon AP
J Biol Chem; 2006 Jun; 281(26):18193-200. PubMed ID: 16638752
[TBL] [Abstract][Full Text] [Related]
13. Herpes simplex virus type 1 DNA polymerase. Mutational analysis of the 3'-5'-exonuclease domain.
Kühn FJ; Knopf CW
J Biol Chem; 1996 Nov; 271(46):29245-54. PubMed ID: 8910584
[TBL] [Abstract][Full Text] [Related]
14. Genotypic characterization of the DNA polymerase and sensitivity to antiviral compounds of foscarnet-resistant herpes simplex virus type 1 (HSV-1) derived from a foscarnet-sensitive HSV-1 strain.
Saijo M; Suzutani T; Morikawa S; Kurane I
Antimicrob Agents Chemother; 2005 Feb; 49(2):606-11. PubMed ID: 15673740
[TBL] [Abstract][Full Text] [Related]
15. Single nucleotide polymorphisms of thymidine kinase and DNA polymerase genes in clinical herpes simplex virus type 1 isolates associated with different resistance phenotypes.
Schubert A; Gentner E; Bohn K; Schwarz M; Mertens T; Sauerbrei A
Antiviral Res; 2014 Jul; 107():16-22. PubMed ID: 24747042
[TBL] [Abstract][Full Text] [Related]
16. Kinetic mechanisms governing stable ribonucleotide incorporation in individual DNA polymerase complexes.
Dahl JM; Wang H; Lázaro JM; Salas M; Lieberman KR
Biochemistry; 2014 Dec; 53(51):8061-76. PubMed ID: 25478721
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic and genotypic characterization of acyclovir-resistant clinical isolates of herpes simplex virus.
Sauerbrei A; Deinhardt S; Zell R; Wutzler P
Antiviral Res; 2010 Jun; 86(3):246-52. PubMed ID: 20211650
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
[TBL] [Abstract][Full Text] [Related]
19. 3'-5' Exonucleolytic activity of DNA polymerases: structural features that allow kinetic discrimination between ribo- and deoxyribonucleotide residues.
Lin TC; Wang CX; Joyce CM; Konigsberg WH
Biochemistry; 2001 Jul; 40(30):8749-55. PubMed ID: 11467934
[TBL] [Abstract][Full Text] [Related]
20. Mutations within conserved motifs in the 3'-5' exonuclease domain of herpes simplex virus DNA polymerase.
Hall JD; Orth KL; Sander KL; Swihart BM; Senese RA
J Gen Virol; 1995 Dec; 76 ( Pt 12)():2999-3008. PubMed ID: 8847505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
